BIRC3 and arthritic joint disease: BIRC3 is a direct target of ATF6α, and model mice with ATF6α deficiency exhibit reduced arthritis progression, resulting in significant reductions in clinical and pro-inflammatory markers in the joints (Ge et al. 2022).